Myeloablative Fractionated Busulfan Conditioning Regimen with Sorafenib in Patients with AML: Results of Phase I Clinical Trial
Year: 2022
Type: article
Authors: Uday R Popat, Rohtesh S. Mehta, Peter Thall, Roland Bassett, Amin M. Alousi, Gheath Al-Atrash, Qaiser Bashir, Chitra Hosing, Jin Seon Im, Partow Kebriaei, David Marin, Yago Nieto, Amanda Olson, Betul Oran, Jeremy Ramdial, Neeraj Y Saini, Samer A Srour, Ben C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Naval Daver, Farhad Ravandi, Elizabeth J Shpall, Richard E Champlin, Borje S. Andersson
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W4221068663